These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 12108796)

  • 1. Attempted abuse of concerta.
    Ciccone PE
    J Am Acad Child Adolesc Psychiatry; 2002 Jul; 41(7):756. PubMed ID: 12108796
    [No Abstract]   [Full Text] [Related]  

  • 2. A case report of Concerta misuse in a patient with comorbid substance use disorder and attention deficit hyperactivity disorder.
    Rizkallah E; Legault L; Pampoulova T; Lévesque S; Bélanger M; Stavro K; Chiasson JP; Potvin S
    Am J Addict; 2011; 20(5):478-9. PubMed ID: 21838849
    [No Abstract]   [Full Text] [Related]  

  • 3. The dual diagnosis of attention-deficit/hyperactivity disorder and substance abuse: case reports and literature review.
    Schubiner H; Tzelepis A; Isaacson JH; Warbasse LH; Zacharek M; Musial J
    J Clin Psychiatry; 1995 Apr; 56(4):146-50. PubMed ID: 7713853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substance use disorders in adolescents with attention-deficit/hyperactivity disorder.
    Bukstein O
    Adolesc Med State Art Rev; 2008 Aug; 19(2):242-53, viii. PubMed ID: 18822830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new long-acting methylphenidate (Concerta).
    Med Lett Drugs Ther; 2000 Sep; 42(1086):80-1. PubMed ID: 10980811
    [No Abstract]   [Full Text] [Related]  

  • 6. Failed attempts at intranasal abuse of Concerta.
    Jaffe SL
    J Am Acad Child Adolesc Psychiatry; 2002 Jan; 41(1):5. PubMed ID: 11800205
    [No Abstract]   [Full Text] [Related]  

  • 7. [The most vulnerable addicts deserted by the National Board of Health and Welfare].
    Modigh K
    Lakartidningen; 2007 May 2-8; 104(18):1426-7; discussion 1427. PubMed ID: 17550018
    [No Abstract]   [Full Text] [Related]  

  • 8. Efficacy of two once-daily methylphenidate formulations compared across dose levels at different times of the day: preliminary indications from a secondary analysis of the COMACS study data.
    Sonuga-Barke EJ; Swanson JM; Coghill D; DeCory HH; Hatch SJ
    BMC Psychiatry; 2004 Sep; 4():28. PubMed ID: 15458569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intranasal abuse of prescribed methylphenidate.
    Garland EJ
    J Am Acad Child Adolesc Psychiatry; 1998 Jun; 37(6):573-4. PubMed ID: 9628076
    [No Abstract]   [Full Text] [Related]  

  • 10. Continuity of methylphenidate treatment for attention-deficit/hyperactivity disorder.
    Marcus SC; Wan GJ; Kemner JE; Olfson M
    Arch Pediatr Adolesc Med; 2005 Jun; 159(6):572-8. PubMed ID: 15939858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substance abuse in adolescents: diagnostic issues derived from studies of attention deficit disorder with hyperactivity.
    Loney J
    NIDA Res Monogr; 1988; 77():19-26. PubMed ID: 3145426
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of attention deficit and borderline personality disorders with psychostimulants: case report.
    Hooberman D; Stern TA
    J Clin Psychiatry; 1984 Oct; 45(10):441-2. PubMed ID: 6480572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychiatric comorbidity among children and adolescents with and without persistent attention-deficit hyperactivity disorder.
    Gau SS; Ni HC; Shang CY; Soong WT; Wu YY; Lin LY; Chiu YN
    Aust N Z J Psychiatry; 2010 Feb; 44(2):135-43. PubMed ID: 20113302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A controlled trial of methylphenidate in adults with attention deficit/hyperactivity disorder and substance use disorders.
    Carpentier PJ; de Jong CA; Dijkstra BA; Verbrugge CA; Krabbe PF
    Addiction; 2005 Dec; 100(12):1868-74. PubMed ID: 16367988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Attention-deficit/hyperactivity disorder and substance abuse].
    Davids E; Gastpar M
    Psychiatr Prax; 2003 May; 30(4):182-6. PubMed ID: 12768521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of long-acting OROS methylphenidate on routine driving in young adults with attention-deficit/hyperactivity disorder.
    Cox DJ; Mikami AY; Cox BS; Coleman MT; Mahmood A; Sood A; Moore M; Burket R; Merkel RL
    Arch Pediatr Adolesc Med; 2008 Aug; 162(8):793-4. PubMed ID: 18678816
    [No Abstract]   [Full Text] [Related]  

  • 17. [Attention deficit hyperactivity disorder, facilitating alcohol and drug abuse in an adult].
    Durst R; Rebaudengo-Rosca P
    Harefuah; 1997 May; 132(9):618-22, 680. PubMed ID: 9225572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of extended release stimulant-based medications on neuropsychological functioning among adolescents with Attention-Deficit/Hyperactivity Disorder.
    Wilson HK; Cox DJ; Merkel RL; Moore M; Coghill D
    Arch Clin Neuropsychol; 2006 Dec; 21(8):797-807. PubMed ID: 17049803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attention deficit hyperactivity disorder and substance use disorders.
    Szobot CM; Bukstein O
    Child Adolesc Psychiatr Clin N Am; 2008 Apr; 17(2):309-23, viii. PubMed ID: 18295148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive predisposition to substance abuse in adult attention deficit hyperactivity disorder.
    Sharps MJ; Price-Sharps JL; Day SS; Villegas AB; Nunes MA
    Addict Behav; 2005 Feb; 30(2):355-9. PubMed ID: 15621407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.